AU2258601A - Ibd-related polymorphisms - Google Patents

Ibd-related polymorphisms

Info

Publication number
AU2258601A
AU2258601A AU22586/01A AU2258601A AU2258601A AU 2258601 A AU2258601 A AU 2258601A AU 22586/01 A AU22586/01 A AU 22586/01A AU 2258601 A AU2258601 A AU 2258601A AU 2258601 A AU2258601 A AU 2258601A
Authority
AU
Australia
Prior art keywords
ibd
related polymorphisms
polymorphisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22586/01A
Other languages
English (en)
Inventor
Mark Daly
Thomas J. Hudson
Eric S. Lander
John Rioux
Kathy Siminovitch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ellipsis Biotherapeutics Corp
Whitehead Institute for Biomedical Research
Original Assignee
Ellipsis Biotherapeutics Corp
Whitehead Institute for Biomedical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ellipsis Biotherapeutics Corp, Whitehead Institute for Biomedical Research filed Critical Ellipsis Biotherapeutics Corp
Publication of AU2258601A publication Critical patent/AU2258601A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU22586/01A 1999-12-10 2000-12-11 Ibd-related polymorphisms Abandoned AU2258601A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17025799P 1999-12-10 1999-12-10
US60170257 1999-12-10
US19604600P 2000-04-10 2000-04-10
US60196046 2000-04-10
PCT/US2000/033632 WO2001042511A2 (fr) 1999-12-10 2000-12-11 Polymorphismes associes aux maladies enteriques inflammatoires

Publications (1)

Publication Number Publication Date
AU2258601A true AU2258601A (en) 2001-06-18

Family

ID=26865891

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22586/01A Abandoned AU2258601A (en) 1999-12-10 2000-12-11 Ibd-related polymorphisms

Country Status (4)

Country Link
EP (1) EP1276899A2 (fr)
AU (1) AU2258601A (fr)
CA (1) CA2394033A1 (fr)
WO (1) WO2001042511A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3885400A (en) * 1999-03-23 2000-10-09 Human Genome Sciences, Inc. 48 human secreted proteins
AU2002348745A1 (en) * 2001-12-21 2003-07-09 Ellipsis Biotherapeutics Corporation Polymorphisms of the OCTN1 and OCTN2 cation transporters associated with inflammatory bowel disease
WO2010062960A2 (fr) 2008-11-26 2010-06-03 Cedars-Sinai Medical Center Méthodes de détermination d'une réceptivité à une thérapie par anti-tnfα lors d’une maladie intestinale inflammatoire
EP3639841B1 (fr) 2013-03-27 2023-09-06 Cedars-Sinai Medical Center Traitement de la fibrose par inhibition de tl1a
EP4105236A1 (fr) 2013-07-19 2022-12-21 Cedars-Sinai Medical Center Anticorps contre tl1a (tnfsf15) pour le traitement des maladies inflammatoires de l'intestin
WO2017161342A1 (fr) 2016-03-17 2017-09-21 Cedars-Sinai Medical Center Méthode de diagnostic d'une maladie inflammatoire chronique de l'intestin par l'intermédiaire de rnase t2
CN108359736B (zh) * 2018-05-23 2020-12-29 华中农业大学 母猪肢蹄骨密度性状的snp遗传标记

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE930961L (en) * 1984-07-06 1986-01-06 Sandoz Ag Lymphokine production and purification
WO1994004196A1 (fr) * 1992-08-14 1994-03-03 Imperial Cancer Research Technology Limited Therapie de tumeurs
US5681699A (en) * 1994-02-11 1997-10-28 Cedars-Sinai Medical Center Methods of diagnosing ulcerative colitis and Crohn's disease
US5916748A (en) * 1996-04-12 1999-06-29 Cedars-Sinai Medical Center Method of diagnosing a clinical subtype of crohn's disease with features of ulcerative colitis
EP0941366A2 (fr) * 1996-11-06 1999-09-15 Whitehead Institute For Biomedical Research Marqueurs bialleliques
WO1998038846A2 (fr) * 1997-03-07 1998-09-11 Affymetrix, Inc. Compositions genetiques et procedes

Also Published As

Publication number Publication date
CA2394033A1 (fr) 2001-06-14
WO2001042511A2 (fr) 2001-06-14
WO2001042511A3 (fr) 2002-11-14
EP1276899A2 (fr) 2003-01-22

Similar Documents

Publication Publication Date Title
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU5967600A (en) Candystraw
AU4115400A (en) Short-circuiter
AU6335000A (en) Depthimeter
AU7514700A (en) Cyanopiperidines
AU6440900A (en) Homogentisate-dioxygenase
AU2023701A (en) Sketcher
AU2804600A (en) Arylaminoalkylamides
AU2699800A (en) Organoceramics
AU4916900A (en) Benzofuranylsulfonates
AU6098300A (en) Follistatin-3
AU2258601A (en) Ibd-related polymorphisms
AU4561600A (en) Benzofuranylaminoalcohols
AU1901801A (en) Glucofuranoses
AU7513400A (en) Hydantoin-racemase
AU1915601A (en) Periotome
AU4435300A (en) Hula-hoop
AU2582200A (en) Windturbine
AU7303400A (en) Osseo-distractor
AU1404901A (en) Cd36 polymorphisms
AU2197301A (en) Microlamp
AU5416100A (en) Retinoscopes
AU1737601A (en) Collectalbum
AU5487300A (en) Benzylpiperazinyl-indolinylethanones

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase